Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2017-11-24

Clinical Trial Update: Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

View source ↗

Summary

The Zenith Fenestrated Abdominal Aortic Aneurysm Endovascular Graft has received marketing approval under the continued access study, enabling expanded use for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zenith Fenestrated Abdominal Aortic Aneurysm Endovascular Graft

Snippet

Sponsor: Cook Group Incorporated | Conditions: Abdominal Aortic Aneurysms, Aorto-iliac Aneurysms | Status: APPROVED_FOR_MARKETING